Verdict Capital
VC Fund
San Francisco, United States
Verdict Capital is a venture capital firm that provides early-stage capital to startups and emerging companies. The firm focuses on identifying and investing in companies at the early stages of development, providing capital to support product development, business expansion, and other growth initiatives. Its investment activities include sourcing opportunities, evaluating companies, conducting due diligence, structuring investments, and managing portfolio relationships. Verdict Capital works with founders and entrepreneurial teams to provide financing and strategic support as companies develop their products and pursue market opportunities. The firm positions itself as a source of “first money,” indicating a focus on early-stage investments rather than later-stage private equity or buyout transactions.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Verdict Capital invests in
Stages Verdict Capital invests in
Countries Verdict Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
Investment Focus
Industry
- Medical 1 (33%)
- Biopharma 1 (33%)
- Simulation 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
Stage
- Seed 2 (67%)
- Pre-Seed 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Michael Fertik
Co-Founder & Managing Director
|
Co-Founder & Managing Director | Total investments: 17 | Find email | |
|
Nikolaos Bonatsos
Co Founder & Managing Director
|
Co Founder & Managing Director | Total investments: 94 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| BioStack Platforms develops data infrastructure and simulation environments for healthcare and drug discovery AI. The company builds proprietary preclinical and clinical data pipelines that connect longitudinal, multimodal medical data such as EHRs, imaging, ECGs, labs, notes, audio, and outcomes. It structures this information intomachine-learning-ready datasets and workflow-aligned simulation environments rather than static text corpora. These environments support post-training, reinforcement learning, and multi-agent reasoning for medical AI systems. BioStack Platforms serves AI labs, biotechnology startups, pharmaceutical teams, and data providers that need domain-specific datasets, causal inference support, and robust reward models. Its offerings are used to test, evaluate, and train medical AI models on real-world clinical workflows before deployment in practice. | $9.5M / Seed / Oct 22, 2026 | ||
| Publik is a platform for discovering and running free, open-source apps, with shared usage-based AI and compute services. On October 18, 2026, Publik announced a $600,000 pre-seed investment from Verdict Capital. This announcement covers the completed investment; the broader pre-seed round may remain open. | $600K / Pre-Seed / Oct 18, 2026 | ||
| Data Movement Governance | $4.2M / Seed / Oct 07, 2026 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Verdict Capital invest in?
Verdict Capital invests primarily in Medical, Biopharma and Simulation startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Verdict Capital?
Public channels for Verdict Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Verdict Capital?
The team at Verdict Capital includes Michael Fertik (Co-Founder & Managing Director) and Nikolaos Bonatsos (Co Founder & Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!